Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
Alicia DeFelipe-Mimbrera(Instituto Cajal), Jaime Masjuán(Universidad de Alcalá), Susana Sainz de la Maza(Universidad de Alcalá), Marta Guillán(Instituto Ramón y Cajal de Investigación Sanitaria), A. Alonso Cánovas(Hospital Universitario Ramón y Cajal), Rocío Vera(Instituto Cajal)
Cited by 5
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
|The Lancet|2012|280
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
|Journal of Clinical Investigation|2005|257